{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:27:14Z","timestamp":1794338834132,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.vaccine.2010.10.070","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T08:40:08Z","timestamp":1288946408000},"page":"8236-8245","source":"Crossref","is-referenced-by-count":34,"title":["WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13\u201314 May 2009"],"prefix":"10.1016","volume":"28","author":[{"given":"Morag","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.10.070_bib0005","series-title":"International health regulations (2005)","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2010.10.070_bib0010","series-title":"Requirements for yellow fever vaccine (requirements for biological substances no. 3)","author":"World Health Organization","year":"1998"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.10.070_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biologicals.2007.11.005","article-title":"WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11\u201312 June 2007","volume":"36","author":"Knezevic","year":"2008","journal-title":"Biologicals"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.10.070_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-1157(83)80045-6","article-title":"A W.H.O. collaborative study of in vitro and in vivo methods for the assay of yellow fever vaccines","volume":"11","author":"Seagroatt","year":"1983","journal-title":"J Biol Stand"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.10.070_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2004.09.003","article-title":"Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine","volume":"32","author":"Ferguson","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.10.070_bib0030","series-title":"International travel and health 2009","author":"World Health Organization","year":"2009"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.10.070_bib0035","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights A report of a workshop held during the World Congress on medicine and health in the tropics Marseille, France, Monday 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"issue":"December (13)","key":"10.1016\/j.vaccine.2010.10.070_bib0040","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.10.070_bib0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.10.070_bib0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.10.070_bib0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"issue":"December (50)","key":"10.1016\/j.vaccine.2010.10.070_bib0060","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.10.070_bib0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.10.070_bib0070","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.10.070_bib0075","doi-asserted-by":"crossref","first-page":"e1000614","DOI":"10.1371\/journal.ppat.1000614","article-title":"A mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"Meier","year":"2009","journal-title":"PLoS Pathog"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2010.10.070_bib0080","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","article-title":"Viscerotropic disease following yellow fever vaccination in Peru","volume":"27","author":"Whittembury","year":"2009","journal-title":"Vaccine"},{"issue":"June (17\u201318)","key":"10.1016\/j.vaccine.2010.10.070_bib0085","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"issue":"November (48)","key":"10.1016\/j.vaccine.2010.10.070_bib0090","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2010.10.070_bib0095","first-page":"287","article-title":"Meeting of Global Advisory Committee on Vaccine Safety 18-19 June 2008","volume":"83","author":"World Health","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2010.10.070_bib0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"July (9276)","key":"10.1016\/j.vaccine.2010.10.070_bib0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2010.10.070_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virology"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.10.070_bib0115","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"issue":"May\u2013June (9\u201310)","key":"10.1016\/j.vaccine.2010.10.070_bib0120","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.10.070_bib0125","first-page":"233","article-title":"IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31\u2013February 1, 2005, Geneva","volume":"34","year":"2006","journal-title":"Biologicals"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.10.070_bib0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biologicals.2005.09.005","article-title":"Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102\/84 with an additional passage in chicken embryos","volume":"34","author":"Marchevsky","year":"2006","journal-title":"Biologicals"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2010.10.070_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0034-89102005000300012","article-title":"Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial","volume":"39","author":"Camacho","year":"2005","journal-title":"Rev Saude Publica"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2010.10.070_bib0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2010.10.070_bib0145","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.10.070_bib0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2010.10.070_bib0155","first-page":"460","article-title":"One case of severe adverse event following to yellow fever vaccination","volume":"44","author":"Huang","year":"2005","journal-title":"Chin J Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.070_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-1157(88)90034-0","article-title":"Studies on yellow fever vaccine. III. Dose response in volunteers","volume":"16","author":"Lopes","year":"1988","journal-title":"J Biol Stand"},{"issue":"3","key":"10.1016\/j.vaccine.2010.10.070_bib0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-1157(77)80003-6","article-title":"Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function","volume":"5","author":"Freestone","year":"1977","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2010.10.070_bib0170","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccines","author":"Monath","year":"2008"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.10.070_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2005.72.339","article-title":"Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.10.070_bib0180","article-title":"Module 8: yellow fever","author":"World Health Organization","year":"1993"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T02:52:57Z","timestamp":1559789577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10015719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":36,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0264410X10015719"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}